Omnipaque
Kidney Hypoxia
Petter BjornstadActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Kidney Hypoxia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
SODIUM P-AMINOHIPPURATE Petter Bjornstad | D | |
DEXTRAN 40 FOR INJECTION Petter Bjornstad | D |
Same molecule, other indications
Omnipaque is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →